Advik Laboratories has informed that a meeting of the Board of Directors of the Company is scheduled to be held on November 14, 2015, to consider and approve the Unaudited Financial Results of the Company for the Quarter and Half Year ended on September 30, 2015.Further, in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the shares of the Company for all Directors / Officers / Designated Employees of the Company, shall remain closed for the purpose of declaration of Unaudited Financial Results of the Company for the Quarter and Half Year ended on September 30, 2015 from November 07, 2015 to November 16, 2015.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.35 |
| Dr. Reddys Lab | 1236.85 |
| Cipla | 1232.80 |
| Zydus Lifesciences | 942.40 |
| Lupin | 2332.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: